140 related articles for article (PubMed ID: 2404502)
21. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording.
Fariello R; Boni E; Corda L; Cantalamessa A; Zaninelli A; Pollavini G; Alicandri C; Muiesan G
Am J Hypertens; 1991 Jan; 4(1 Pt 1):27-33. PubMed ID: 2006994
[TBL] [Abstract][Full Text] [Related]
22. Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension--a randomized, double-blind, crossover study.
Koenig W; Sund M; Ernst E; Hehr R; Binner L; Rosenthal J; Hombach V
J Intern Med; 1991 Jun; 229(6):533-8. PubMed ID: 2045762
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China].
Chen YY; Sun NL; Zhang WZ; Wu HY; Zhang L; Yu ZQ; Zhang FC; Xiang XP; Liu HL; Shen FR; Tao J; Zhao JA
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):619-23. PubMed ID: 18087554
[TBL] [Abstract][Full Text] [Related]
24. Clinical equivalence of two tablet formulations of felodipine. A placebo-controlled study of 24-hour blood pressure control and tolerability.
McGrath BP; Watts RW; Elmfeldt DB
Eur J Clin Pharmacol; 1995; 49(3):169-72. PubMed ID: 8665991
[TBL] [Abstract][Full Text] [Related]
25. Clinical trial of extended-release felodipine in pediatric essential hypertension.
Trachtman H; Frank R; Mahan JD; Portman R; Restaino I; Matoo TK; Tou C; Klibaner M
Pediatr Nephrol; 2003 Jun; 18(6):548-53. PubMed ID: 12700955
[TBL] [Abstract][Full Text] [Related]
26. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
Hosie J; Dahlöf B; Klein G
Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
[TBL] [Abstract][Full Text] [Related]
27. The influence of infusion rate on the hemodynamic effects of felodipine.
Cohen AF; van Hall MA; van Harten J; Schoemaker RC; Johansson P; Breimer DD; Visser R; Edgar B
Clin Pharmacol Ther; 1990 Sep; 48(3):309-17. PubMed ID: 2401128
[TBL] [Abstract][Full Text] [Related]
28. Comparison of verapamil versus felodipine on heart rate variability in hypertensive patients.
Petretta M; Canonico V; Madrid A; Mickiewicz M; Spinelli L; Marciano F; Vetrano A; Signorini A; Bonaduce D
J Hypertens; 1999 May; 17(5):707-13. PubMed ID: 10403616
[TBL] [Abstract][Full Text] [Related]
29. Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability.
Xu M; Wu Y; Wang H; Xu X; Zhao S; Zhang M; Jin H; Yan J; Wang B; Gong J; Lu X; Peng J; Dai Q
Curr Med Res Opin; 2016 Oct; 32(sup2):43-52. PubMed ID: 27779454
[TBL] [Abstract][Full Text] [Related]
30. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
31. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology.
Zhao S; Yu F; Liu N; Di Z; Yan K; Liu Y; Li Y; Zhang H; Yang Y; Yang Z; Li Z; Mei X
Drug Dev Ind Pharm; 2016 Nov; 42(11):1723-31. PubMed ID: 27074758
[TBL] [Abstract][Full Text] [Related]
32. Felodipine clinical pharmacokinetics.
Dunselman PH; Edgar B
Clin Pharmacokinet; 1991 Dec; 21(6):418-30. PubMed ID: 1782737
[TBL] [Abstract][Full Text] [Related]
33. Impact of the intragastric location of extended release tablets on food interactions.
Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
35. Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.
Cvetković RS; Plosker GL
Drugs; 2005; 65(13):1851-68. PubMed ID: 16114982
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine.
Abrahamsson B; Johansson D; Torstensson A; Wingstrand K
Pharm Res; 1994 Aug; 11(8):1093-7. PubMed ID: 7971707
[TBL] [Abstract][Full Text] [Related]
37. Felodipine once daily in elderly hypertensives. Binational MC Study Group (United Kingdom and Netherlands).
Hosie J; Mulder AW; Westberg B
J Hum Hypertens; 1991 Feb; 5(1):49-53. PubMed ID: 2041036
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
39. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
40. Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion.
Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
Drug Deliv Transl Res; 2018 Feb; 8(1):204-225. PubMed ID: 29204927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
